Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cassie Liu

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Journal of Virology|December 19, 2014
Improving neutralization potency and breadth by combining broadly reactive HIV-1 antibodies targeting major neutralization epitopesRui Kong, Mark K Louder, Kshitij Wagh, et al.
Cell|August 19, 2014
Broadly neutralizing antibodies and viral inducers decrease rebound from HIV-1 latent reservoirs in humanized miceAriel Halper-Stromberg, Ching-Lan Lu, Florian Klein, et al.
Plos Pathogens|October 31, 2015
A New Glycan-Dependent CD4-Binding Site Neutralizing Antibody Exerts Pressure on HIV-1 In VivoNatalia T Freund, Joshua A Horwitz, Lilian Nogueira, et al.
The Journal of Experimental Medicine|November 12, 2014
Enhanced HIV-1 immunotherapy by commonly arising antibodies that target virus escape variantsFlorian Klein, Lilian Nogueira, Yoshiaki Nishimura, et al.
Cell|June 20, 2015
Immunization for HIV-1 Broadly Neutralizing Antibodies in Human Ig Knockin MicePia Dosenovic, Lotta von Boehmer, Amelia Escolano, et al.
Nature Cancer|March 8, 2022
An anti-PD-1-GITR-L bispecific agonist induces GITR clustering-mediated T cell activation for cancer immunotherapySarah Chan, Nicole Belmar, Sun Ho, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Journal of Virology|December 19, 2014
Improving neutralization potency and breadth by combining broadly reactive HIV-1 antibodies targeting major neutralization epitopesRui Kong, Mark K Louder, Kshitij Wagh, et al.
Cell|August 19, 2014
Broadly neutralizing antibodies and viral inducers decrease rebound from HIV-1 latent reservoirs in humanized miceAriel Halper-Stromberg, Ching-Lan Lu, Florian Klein, et al.
Plos Pathogens|October 31, 2015
A New Glycan-Dependent CD4-Binding Site Neutralizing Antibody Exerts Pressure on HIV-1 In VivoNatalia T Freund, Joshua A Horwitz, Lilian Nogueira, et al.
The Journal of Experimental Medicine|November 12, 2014
Enhanced HIV-1 immunotherapy by commonly arising antibodies that target virus escape variantsFlorian Klein, Lilian Nogueira, Yoshiaki Nishimura, et al.
Cell|June 20, 2015
Immunization for HIV-1 Broadly Neutralizing Antibodies in Human Ig Knockin MicePia Dosenovic, Lotta von Boehmer, Amelia Escolano, et al.
Nature Cancer|March 8, 2022
An anti-PD-1-GITR-L bispecific agonist induces GITR clustering-mediated T cell activation for cancer immunotherapySarah Chan, Nicole Belmar, Sun Ho, et al.
Pageof 2